Traditionally, the renin angiotensin system (RAS) has been thought of
primarily as an endocrine system that delivers circulating angiotensin
II to target tissues. This peptide is a potent vasoconstrictor and a
primary stimulus for aldosterone secretion. In addition, angiotensin I
I has many other targets such as kidney, heart and brain, from which i
t elicits different specific responses. Numerous studies using pharmac
ologic or immunologic inhibitors of the system have shown an important
role for the circulating RAS in blood pressure and electrolyte as wel
l as fluid homeostasis. Although it acts as a classical circulating en
docrine system, there is increasing evidence to show that the RAS may
also have an important local autocrine or paracrine role in a variety
of tissues since it has been shown that the RAS components are present
in all of these tissues. In addition, several investigators recently
demonstrated the expression of renin and angiotensinogen genes in mult
iple tissues, which strongly suggests that these proteins are locally
synthesized. Moreover, it has been demonstrated that tissue RAS is ind
ependently regulated from circulating system under different pathologi
cal situations such as hypertension. As a result, the concept of the R
AS as an endocrine system alone is in question. Locally expressed RAS
may be involved with the regulation of individual tissue function inde
pendent of the circulating counterpart. However, the importance of the
se local systems in circulatory control and body volume homeostasis ha
s yet to be defined. It has been proposed that the main function of th
e circulating RAS is to provide short-term cardiorenal homeostasis. Th
e tonic control (e.g., adrenal and kidney) is influenced by the intrin
sic tissue RAS. This new concept provides a broader outlook on the RAS
and challenges its traditional endocrine role.